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Objectives. This retrospective analysis was performed to assess 
the medium-term effectiveness of implanting intracoronary stents 
into chronic total occlusions that are successfully opened by 
balloon angioplasty. 
Background. The value of percutaneous transluminal coronary 
angioplasty of chronic total occlusions i  limited by a very high 
restenosis rate of 50% to 68%. Intravascular stents have been 
shown to reduce restenosis in a subset of patients with subtotal 
stenoses. It has not been demonstrated that the placement of 
stents into successfully opened chronic total coronary artery 
occlusions leads to lower rates of restenosis. 
Methods. A consecutive series of patients with chronic total 
coronary occlusions uccessfully opened by balloon angioplasty 
received Palmaz-Schatz stents. Patients underwent clinical and 
angiographic follow.up at a mean of 6 months after stent inser- 
tion. Angiographic and clinical results were retrospectively ana- 
lyzed. 
Results. Fifty-nine patients underwent stenting of 60 chronic 
total coronary occlusions, with a 98% rate of successful stent 
deployment. Complications occurred in 5% of cases, all with 
subacute thrombosis. Angiographic follow-up was obtained in 88% 
of patients at a mean of 6 months and demonstrated an angio- 
graphic restenosis rate of 20%, with only one reocclusion. Among 
several variables examined, only the presence of a procedure- 
related moderate to severe dissection was associated with higher 
follow-up ercent diameter stenoses and clinical events. At a mean 
of 14 months after stent insertion, 77% of patients remained free 
of symptoms or clinical events. 
Conclusions. The implantation of intracoronary stents into 
vessels with opened chronic total coronary occlusions is associ- 
ated with favorable rates of angiographic restenosis and relief of 
symptoms. A randomized clinical trial comparing balloon angio- 
plasty with stent-assisted balloon angioplasty in the treatment of
chronic total coronary occlusions i  indicated. 
(J Am Coil Cardiol 1995;26:713-9) 
Percutaneous transluminal coronary angioplasty of chronic 
total coronary occlusions has been associated with disappoint- 
ingly high rates of restenosis, -50% to 68% (1). Partly for this 
reason, a chronic total occlusion is often considered to be a 
relative contraindication to coronary angioplasty, and many 
patients are referred for coronary artery bypass graft surgery. 
Recently, intracoronary stent implantation has been used 
adjunctively with balloon angioplasty as a means to lower 
restenosis inselected patients (2,3). For the previous 3years all 
patients presenting to Columbus Hospital in Milan, Italy with 
a chronic total coronary occlusion successfully opened with 
angioplasty have received balloon-expandable Palmaz-Schatz 
stents (Johnson and Johnson Interventional Systems). The 
immediate results in the first several patients undergoing stent 
implantation at this center for chronic total occlusion have 
been published previously (4). The present study is a retro- 
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spective analysis of the short- and medium-term results in a 
consecutive s ries of 59 patients. 
Methods  
Patients. From December 1989 to July 1993, all patients 
presenting with signs of ischemia nd a chronic total occlusion 
underwent Palmaz-Schatz stent deployment in the lesion, 
provided that the lesion could be successfully opened with 
balloon angioplasty. A chronic total occlusion was defined as 
complete interruption of the vessel with Thrombolysis in 
Myocardial Infarction (TIMI) grade 0 or 1 flow (5) that was at 
least 3 days old. Patients with total occlusions due to acute 
dissections have been presented previously and are not in- 
cluded in the present analysis (6). No attempt at stent deploy- 
ment was made if the occlusion could not be opened or if 
extensive spiral dissection prevented i entification ofthe guide 
wire in the true lumen distally. A total of 59 patients under- 
went stent implantation for 60 lesions and comprise the study 
group. 
Procedure. All patients underwent balloon angioplasty to 
open the occlusions using techniques described previously 
(4,7). Rotational ablation was performed in one patient, and 
another had directional atherectomy before stent implanta- 
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tion, in addition to balloon angioplasty. Once the vessel was 
opened, and the guide wire identified within the true lumen 
distal to the occlusion, one or more Palmaz-Schatz stents were 
placed by being manually crimped on a balloon, which deliv- 
ered it to the lesion (4,8). Care was taken to completely cover 
newly developed issections with stents (6). Whenever possible 
distal stents were placed first if multiple stents were required. 
If, however, a stent needed to be placed distal to a previously 
deployed stent, a hemiarticulated half-stent was used (8). 
The final 12 patients in the series underwent intravascular 
ultrasound imaging (Intertherapy) during stent deployment, 
with further balloon inflations as needed to optimize the 
intravascular ultrasound appearance of stent expansion, as has 
been described previously (9,10). All patients except he final 
eight in the series received a standard anticoagulation regimen 
with heparin, dextran and coumadin, as well as antiplatelet 
therapy with either aspirin and dypridamole or ticlopidine (6). 
The final eight patients in the series, all of whom had intra- 
vascular ultrasound assessment of stent expansion, were 
treated with routine heparin during the procedure but not 
afterward, were not given dextran or coumadin and were 
discharged with ticlopidine as the only medication to prevent 
clotting (11). Patients were instructed to return for routine 
follow-up angiography 6 months after stent implantation. 
Clinical evaluation was obtained at that time, with further 
follow-up by telephone. 
The patients' charts were examined to estimate the time of 
closure of the vessel, which was categorized as <-3 or >3 
months. Any occlusion judged to be <3 days old was excluded 
from the study. The films were reviewed to verify, that a total 
occlusion was present and that there was no evidence of abrupt 
closure. 
Quantitative coronary angiography. Quantitative coro- 
nary angiography was retrospectively performed by a single 
experienced investigator (S.L.G.). Digital electronic alipers. 
using the guiding catheter filled with contrast medium as a 
scaling device, were used to measure the reference lumen 
diameter, final minimal lumen diameter and length of the 
stenosis after it was opened. The reference lumen diameter 
was taken to be the average of the diameters of normal- 
appearing segments proximal and distal to the occlusion after 
it was reopened. The lesions were assessed in at least two 
orthogonal views, and the projection showing the smallest 
minimal lumen diameter was selected for measurements. The 
reference lumen and minimal lumen lesion diameters were 
also measured on the follow-up film. Follow-up percent steno- 
sis was then calculated, using the follow-up reference lumen 
measurement or the reference lumen at the time of the 
procedure if it was larger (12). lf a narrowed segment was 
present adjacent o the stented segment, the minimal lumen 
diameter in the narrowed segment was used. A binary defini- 
tion of restenosis was used and defined as ->5(1% stenosis on 
follow-up angiography. A clinical event was defined as death. 
myocardial infarction or target lesion revascularization. 
Several other angiographic features were evaluated: total 
versus functional occlusion (TIMI grade 0 vs. grade 1 flow), 
Table I. Clinical Characteristics of 59 Study Patients 
Age (yr) (mean + SD) 55 + 10 
Men 97% 
Angina class Ill or 1V 42% 
Prior myocardial infarction 59% 
Prior dilation 29% 
Stenosis duration 
< I wk 0% 
->l wk, -<3 mo 29% 
>3 mo 49% 
Unable to estimate 22% 
Multiple stems 39% 
Average no. of stents/pt 1.6 
Stentcd vessel 
LAD 22 (37%) 
Cx 13 (22%) 
RCA 22 (37%) 
SVG 2 (3%) 
Data presented are percent or number (%) of patients, unless otherwise 
indicated. Cx = circumflex coronary artery; LAD = left anterior descending 
coronary artery'; pt - patient; RCA = right coronary artery; SVG - saphenous 
vein graft. 
presence or absence of fluoroscopic alcification, bridging 
collateral flow, collateral flow from other vessels, dissection 
during the procedure and extent of any dissection. A dissection 
was characterized as mild if it was small and linear with no 
suggestion of vessel compromise, moderate if the dissection did 
not appear to extend beyond the length of the lesion or severe 
if it extended outside the length of the stenosis. 
Statistics. Data are presented as mean value _+ SD. Cate- 
goric variables were compared using the Fisher exact test. 
Continuous variables were compared by analysis of variance. 
Multivariate analyses using general inear regression for con- 
tinuous outcome variables or logistic regression for categoric 
outcome variables was performed for variables found to have 
p values <0.1 by univariate analyses. A p value <0.05 was 
considered significant. Statistical analyses were performed 
using SYSTAT software. 
Resu l ts  
A total of 707 patients received intracoronary stents at 
Centro Cuore Columbus hospital from December 1989 to July 
1993, with chronic total occlusion listed as the indication in 68 
lesions. After film and chart review, eight films were found to 
show subtotal stenoses or abrupt occlusions that occurred 
during or within 2 days of an intervention. These were ex- 
cluded, leaving chronic total occlusion as the indication in 60 
lesions in 59 patients (8.3% of stented lesions). One patient 
had a total occlusion of the mid-left anterior descending 
coronary, artery, with right-to-left collateral flow and a mid- 
right coronary occlusion with left-to-right collateral flow. 
Clinical/lesion characteristics. Clinical characteristics of 
the patients are presented in Table 1. Forty-two percent of 
patients had Canadian Cardiovascular Society class III or IV 
angina and 58% class I or lI angina. The estimation of the time 
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of occlusion ranged from 1 week to 10 years, with the occlusion 
judged to be <-3 months old in 17 patients (29%) and >3 
months old in 29 patients (49%). Assessment of occlusion 
duration was not possible in 13 patients (22%). 
Seventy-four standard Palmaz-Schatz stents, 25 hemiarticu- 
lated half-stents and 11 biliary Palmaz stents were placed in the 
59 vessels. Forty-three percent of lesions received multiple 
stents. 
Procedural and in-hospital events. Stent implantation was 
successfully performed in 59 (98%) of 60 lesions. Complica- 
tions occurred in three patients (5%), all with subacute throm- 
bosis. The only vascular complication (2%) was bleeding from 
the groin puncture site, necessitating discontinuation f anti- 
coagulation, with subacute thrombosis occurring shortly after- 
ward. One non-Q wave myocardial infarction (2%) occurred 
secondary to subacute thrombosis. Two patients underwent 
angioplasty to treat subacute thrombosis. There were no 
deaths or referrals for coronary artery bypass graft surgery. 
The 3 patients with subacute thrombosis were among the 
first 20 in the series and were treated with the traditional 
anticoagulation regimen. There was a trend toward occurrence 
of subacute thrombosis and the presence of a severe dissection 
(p = 0.06) but no correlation with the use of multiple stents, 
reference lumen diameter or final minimal lumen diameter. 
Two of the three patients were successfully treated with 
emergent angioplasty. The third patient was'treated medically 
and sustained a non-Q wave myocardial infarction. 
Clinical follow-up. All patients had clinical follow-up at a 
mean of 14 _+ 11 months (range 2 to 43). At 14 months, 77% 
patients were asymptomatic and free of clinical events, defined 
as death, myocardial infarction or target lesion revasculariza- 
tion. There was one death of unclear cause and one myocar- 
dial infarction (2% each). Nine patients underwent repeat 
angioplasty (seven for restenosis at the stent site, two for new 
lesions in other vessels). One patient with asymptomatic 
restenosis at 6 months underwent repeat angioplasty at 1 year 
after developing angina. Two patients (4%) underwent coro- 
nary artery bypass graft surgery 14 and 18 months after 
stenting, respectively. Both of these patients had angioplasty 
for restenosis at the 6-month follow-up, and one had a 
myocardial infarction 12 months after stent implantation. The 
overall incidence of target lesion revascularization was 14% 
(n = 8). 
Two of the three patients with subacute thrombosis had 
successful repeat angioplasty at the time of stent closure. Both 
of these patients had patent vessels on 6-month angiography 
and have remained asymptomatic. 
Early and late angiographic findings. All patients had 
quantitative coronary measurements performed on the stent- 
deployment angiograms. Angiographic dimensions are dis- 
played in Table 2. Mean reference lumen diameter was 3.0 +_ 
0.5 mm (range 2.2 to 5.0) and mean postprocedural minimal 
lumen diameter 3.0 _+ 0.4 ram. Mean lesion length was 12 _+ 
7 mm (range 3 to 35). 
Angiographic follow-up was accomplished in 50 (88%) of 
57 eligible patients at a mean of 6 _+ 4 months (range 2 to 29). 
Table 2. Angiographic Measurements 
Baseline 
Reference lumen diameter (ram) 3.0 ± 0.5 
Minimal lumen diameter after stenting (ram) 3.0 ± 0.4 
Length of lesion (mm) 12 - 7 
% stenosis after stenting 0 ± 11 
Follow-up 
Duration (too) 6 ± 4 
Reference diameter (ram) 2.7 ± 0.6* 
Minimal lumen diameter (ram) 2.1 -- 0.7* 
% stenosis 19 ± 25* 
->50% stenosis at follow-up 20% (10/'51) 
*p < 0.0001 versus result at intervention. Data presented are mean value _+ 
SD or percent (number of patients). 
Two patients were not considered eligible for follow-up an- 
giography: the patient with unsuccessful stent implantation and 
the patient with the subacute closure of the vessel that was not 
reopened. One patient died, and seven refused follow-up 
angiography. Follow-up films were available for quantitative 
angiographic measurements for 43 (84%) of the 51 lesions. 
Eight patients had their angiographic follow-up performed in 
other cities, and the films were not available for quantitative 
angiography. In these cases the presence or absence of resten- 
osis was based on the angiographer's vi ual assessment of the 
follow-up percent diameter stenosis. 
The reference lumen diameter decreased by an average of 
0.2 to 2.7 _+ 0.6 ram; and the postprocedural minimal umen 
diameter decreased by an average of 0.9 to 2.1 + 0.7 mm at 
follow-up. Mean percent stenosis increased from 0 _+ 11% at 
the end of the procedure to 19 _+ 25% at follow-up. 
Angiographic restenosis was found in 10 (20%) of 51 
lesions. Only one patient had a recurrent total occlusion; the 
other nine patients had subtotal stenoses. The patient with 
total reocclusion had an extensive dissection present after the 
total occlusion was opened. This dissection, which could not be 
completely covered by stents, had only TIMI grade 2 flow after 
stent implantation and was therefore a less than optimal result. 
Eight patients with restenosis underwent successful redilation. 
Potential markers of restenosis or clinical events. No 
difference was seen between patients with and without angio- 
graphic restenosis with regard to the following clinical vari- 
ables (Table 3): age, gender, presence of unstable angina, 
vessel being stented, occlusion >3 months or previous dilation 
of the vessel. None of the following angiographic variables 
were predictive of angiographic restenosis: functional versus 
total occlusion, presence of dissection, fluoroscopic alcifica- 
tion, bridging collateral vessels or collateral flow from other 
vessels, reference lumen diameter, minimal lumen diameter 
after stenting or lesion length. There was a trend toward 
increased restenosis when a moderate to severe dissection was 
present (p -- 0.07). The use of intravascular ultrasound or 
postprocedural coumadin therapy was not associated with a 
different rate of restenosis. One of the eight patients treated 
without anticoagulation was judged to have restenosis. 
When follow-up minimal umen diameter was evaluated as 
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Table 3. Clinical and Angiographic Characteristics of Patients With 
Versus Without Angiographic Restenosis 
With Without p 
Rcstcnosis Restenosis Value 
Age (yr} s4 ~ 7 55 + 10 il.~ 
Gender (c;- male) lli(~ t18 05) 
Prior angioplasty (c4) 40 32 (1.7 
Unstable angina (%) 23 18 0.7 
Occlusion >3 mn (%) (~ql 63 0.t~ 
Multiple stents (%) ¢~i) (~ ] [)tl 
Final balloon size {ram) ~4 - 0.3 3.7 + 1/.6 1i.2 
Ejection fraction (%) 57 - 11 57 * 7 ql c) 
Dissection present {%) 7(! 6t'~ 05) 
Moderate or severe dissection (";) ¢~11 27 0.07 
Functional occlusion (TIMI 1) (G) Ill 3-1 0.2 
Bridging collateral vessels (c}) Ill 2[) 0.7 
Collateral flow from other ,~t~ S4 0.O 
collateral vessels (%) 
Calcification on fluoroscopy (c~) 4t) 29 (I.7 
Reference lumen diameter (ram} 2.8 ~ 0.3 25) + 0.5 04 
Minimal lumen diameter (ram) 2.t~ - 11.3 2.9 + 0.5 0.7 
Lesion length (ram) I1 + 5 12 _+ 7 ti.7 
Final c;{ stenosis 2 + 13 I + 11 0.5 
% LAD 41i 5~ 0. t) 
% RCA 4~ 2O Ik? 
Single-vessel disease U;) 511 56 11.7 
Echocardiographic guidance (%) lil 24 0.4 
Data presented are mean value - SI) or percent of patients. TIMI 
Thrombolysis n Myocardial Infarction: other abbreviations a, in Table 1. 
an outcome variable, a larger reference lumen diameter (p - 
0.02), a larger final minimal lumen diameter (p = 0.003), the 
absence of a moderate to severe dissection (p - 0.05) and the 
use of echocardiographic guidance (p < 0.001) were all 
predictors of larger follow-up minimal lumen diameter by 
univariate analysis. However, when each of these variables was 
included in a multivariate linear regression model, only the 
absence of a moderate to severe dissection remained a bor- 
derline significant predictor of follow-up minimal umen diam- 
eter (p = 0.07). 
Variables significantly predictive by univariate analysis of 
the follow-up lesion percent diameter stenosis included the 
presence of a moderate to severe dissection (35 +_ 27% with vs. 
11 _+ 20% without a moderate to severe dissection, p = 0.002) 
or the lesion located in the right coronary artery (30 + 20%: for 
right coronary artery lesions vs. 14 ± 26% for other vessels, 
p - 0.05). There was a trend toward lower follow-up percent 
stenosis with the use of echocardiographic guidance (22 ± 24(:~ 
without vs. 5 + 26% with echocardiographic guidance, p - 
0.07). By multivariate analysis, only the presence of moderate 
to severe dissection was predictive of the follow-up percent 
stenosis (p -- 0.03). 
The same variables were also evaluated for associations 
with clinical events, which included death, myocardial infarc- 
tion or target lesion revascularization. The presence of a 
moderate to severe dissection was associated with a trend 
toward the occurrence of a clinical event (p = 0.07). Patients 
presenting with TIMI 0 versus TIMI 1 flow were also statisti- 
cally more likely to have a clinical event (28% vs. 0%, p = 
0.03). However, by logistic regression analysis, neither variable 
achieved statistical significance. 
Discussion 
Chronic total occlusions are found in -10% to 20% of 
patients referred for angioplasty (13,14), Percutaneous revas- 
cularization has been less successful for these lesions than for 
subtotal stenoses (1,15-17). Approximately 73% of chronic 
total occlusions can be successfully opened with angioplasty by 
experienced operators (7). However, despite advances in re- 
cent technology making it easier to open a chronic total 
occlusion, restenosis rates of -68% limit the long-term benefit 
of nonsurgical intervention (1). This restenosis rate has been 
associated with a significantly increased incidence of clinical 
events, such as repeat revascularization, death or myocardial 
infarction, compared with subtotal stenoses (15). Many pa- 
tients with chronic total occlusions are therefore referred for 
coronary, artery bypass graft surgery, even in the presence of 
single-vessel coronary artery disease. 
The use of intracoronary stent implantation leads to a 
significant reduction in restenosis compared with that for 
percutaneous balloon angioplasty in selected patients (2,3); 
however, the benefit of implanting stents in chronic total 
occlusions has not been evaluated extensively. In a retrospec- 
tive analysis of registry data, Ellis et al. (18) noted an increased 
restenosis rate in patients undergoing stent implantation for 
chronic total occlusions compared with subtotal stenoses. In 
the observational study reported here, 59 consecutive patients 
with 60 chronic total occlusions received stents and were 
evaluated for angiographic and clinical evidence of restenosis. 
Angiographic follow-up was performed in 88% of eligible 
patients at a mean of 6 months with additional clinical 
follow-up obtained at a mean of 14 months in all patients. Ten 
(20%) of 51 patients undergoing angiographic follow-up had 
restenosis on the basis of a lumen diameter -<50% of an 
average reference diameter. This compares favorably with the 
rates of -68% in published reports when balloon angioplasty 
alone has been used for this entity (1,16,17,19-23). Further- 
more, only I of the 10 patients with restenosis had a recurrence 
of total occlusion; the other 9 presented with subtotal stenoses 
amenable to repeat dilation. These encouraging results provide 
support for elective stent implantation of chronic total coro- 
nary occlusions as an alternative to operation. 
Risk factors for restenosis. Several features were evalu- 
ated as possible risk factors for restenosis after stents were 
deployed in chronic total occlusions. Older occlusions and 
occlusions with TIMI 0 as opposed to TIMI 1 flow have been 
correlated with restenosis after balloon angioplasty (16,20, 
21,24). However, neither of these factors was found to be 
related to restenosis in the present study, where a strategy of 
stenting total occlusions was used (Table 3). However, TIMI 0 
lesions were associated with an increased likelihood of having 
a clinical event. An additional 20 other clinical or angiographic 
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features were evaluated as possible predictors of restenosis, 
but the only positive finding was a trend toward increased 
restenosis seen in lesions with moderate to severe dissections. 
Other investigators (2,25-27) have noted a relation between 
follow-up percent stenosis of a stented segment with the 
angiographic variables of final minimal umen diameter and 
final percent diameter stenosis. Rcstenotic lesions, those re- 
quiring multiple stents and left anterior descending artery 
stenoses have also been associated with higher ates of resten- 
osis (18,26,27). The failure of these variables to be predictive 
of follow-up percent stenosis or restenosis n the present study 
could be a reflection of the small numbers evaluated, although 
it may be that occluded lesions behave differently after stent 
implantation than subtotally stenotic lesions. 
With follow-up minimal umen diameter as the outcome 
variable, final minimal lumen diameter, eference lumen diam- 
eter, use of echocardiographic guidance and presence of a 
moderate to severe dissection were predictive variables. How- 
ever, by multivariate analysis, only the presence of a moderate 
to severe dissection continued to have borderline significance. 
When percent diameter stenosis on the follow-up anglo- 
gram was evaluated as an end point, the presence of a 
moderate to severe dissection or a right coronary artery lesion 
was both predictive of increased stenoses by univariate analy- 
sis. By multivariate linear egression analysis only the presence 
of a moderate to severe dissection was associated with a larger 
6-month percent diameter stenosis. 
The presence of a moderate to severe dissection is the only 
variable that is associated with less favorable results at follow- 
up, across all outcome variables analyzed. The explanation of
this finding cannot be gleaned from the data presented here 
but may represent a reflection of the results een with stenting 
of subtotal esions. Several investigators (28-32) have ob- 
served increased restenosis when stents are used to treat 
dissections as opposed to other indications, which does not 
appear to be related to the use of multiple stents. Extensive 
dissections are frequent after opening of chronic total occlu- 
sions, presumably because the guide wire traverses through a
dissection plane en route to the distal lumen. Perhaps the 
extensive ndothelial destruction leads to a greater release of 
humoral factors with a resultant increase in inflammatory 
response, platelet aggregation, coagulability or intimal hyper- 
plasia. The prestent development of a moderate to severe 
dissection, a relatively common occurrence, may have con- 
founded the potential impact of final minimal umen diameter 
and percent diameter stenosis for our cohort, which have been 
significant predictors of outcomes for stented vessels in most 
other series. 
The increased percent diameter stenosis in right coronary 
arteries is somewhat at variance with the findings of Carrozza 
et al. (27), who noted an increased rate of restenosis within 
stented left anterior descending arteries compared with that 
within right coronary arteries. This difference may reflect he 
increased incidence in the present cohort of moderate to 
severe dissections een in right coronary arteries compared 
with other vessels (62% vs. 23%, p < 0.01). 
Although TIMI flow before intervention was not predictive 
of restenosis, follow-up minimal umen diameter or percent 
diameter stenosis, patients with functional occlusions (TIMI 
grade l flow) were less likely to have clinical events than those 
with TIMI 0 flow. The potential for a spurious relation of TIMI 
flow and clinical events is high, given the lack of association of 
TIMI 0 flow with follow-up percent stenosis, the small numbers 
of patients and the multiple variables analyzed. By multivariate 
logistic regression analysis, TIMI flow was not significantly 
associated with clinical events. 
Mechanism of benefit. Because this study did not compare 
stenting with routine angioplasty for chronic total occlusions, it
is possible only to speculate on possible mechanisms inwhich 
the addition of stents might lower the rate of restenosis. 
Previous investigators (25) found a significant relation between 
the greater "acute gain" and larger final minimal lumen 
diameter achieved with stent implantation than with balloon 
angioplasty alone. The improvements in lumen dimension seen 
with the addition of stents to the angioplasty procedure appear 
to be a likely contributor to the favorable results seen in the 
present study. This difference in acute gain between balloon 
angioplasty and the addition of a stent for a total occlusion is 
illustrated by the angiograms and intravascular ultrasound 
images from a patient who underwent stenting of a chronic 
total occlusion with intravascular ultrasound guidance, as 
shown in Figure 1. After the lesion was opened with balloon 
angioplasty, a successful angiographic appearance was seen, 
but by intravascular ultrasound, >80% of the vessel volume 
comprised plaque. After a stent was placed, an improved 
angiographic appearance can be appreciated as well as a 
substantial increase in lumen cross-sectional rea seen by 
intravascular ultrasound. 
Alternatively, stents may limit dissection-induced reclosure. 
Moderate to large dissections were fairly frequent, occurring in 
37% of lesions in the present study. Although they were 
associated with a less favorable outcome than lesions lacking 
significant dissections, it may be that without stents an even 
higher incidence of restenosis, even reocclusion, would have 
been seen. A dissection-related reocclusion after balloon an- 
gioplasty of a chronic occlusion might occur very shortly after 
the procedure yet not present clinically as an abrupt occlusion 
because of previously established collateral flow, detected only 
with follow-up angiography. This would inflate the restenosis 
rate, even if the mechanism were abrupt occlusion. Preventing 
these occlusive episodes would produce a more favorable 
restenosis rate. In the present study of stented chronic occlu- 
sions, only one patient had a reocclusion at 6-month angiog- 
raphy. This patient had a suboptimal result with TIMI 2 flow 
and uncovered issection, which would have been prone to 
abrupt closure. 
An additional theoretic benefit of stents is the scaffolding 
potential to limit chronic recoil, which may be more significant 
with the larger, organized plaque burden seen with chronic 
total occlusions. 
Study limitations. The present study was a retrospective 
analysis, and therefore conclusions regarding the benefit of 
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Figure 1. Angiographic and intravascular ultrasound images before 
and after angioplasty and stent deployment i  a complete occlusion of 
the mid-left anterior descending coronary artery. Left, Preintervention 
angiogram demonstrating complete occlusion with Thrombolysis in 
Myocardial Infarction (TIMI) I flow. Top center, Angiogram after 
successful balloon angioplasty showing acceptable r sult. Bottom cen- 
ter, Corresponding intravascular ultrasound image showing a large 
residual plaque ncompassing the intravascular ultrasound catheter 
(C). The lumen border is highlighted by the white line. Top right, 
Improved angiographic appearance is seen after stent deployment. 
Bottom right, Corresponding i travascular ultrasound image demon- 
strates markedly improved lumen [white line) after stent implantation. 
Arrows indicate l sion site. 
stenting of chronic total occlusions compared with that of 
balloon angioplasty are limited. However, the favorable resten- 
osis rate in this observational study, when compared with 
published historical control data, does suggest a potential 
advantage of stenting for this difficult clinical condition. 
Angiographic follow-up was available in 88% of the patients 
in the present study. Most previous studies (13,15,21,22) of
balloon angioplasty for total occlusions had lower angiographic 
follow-up rates of -50%. The restenosis rates from those 
studies may have been artificially inflated as a result of higher 
relative percentages of symptomatic patients undergoing fol- 
low-up angiography. This could dilute the benefit suggested by 
the present study, in which a higher rate of angiographic 
follow-up was obtained. However, the results of balloon angio- 
plasty for chronic total occlusion were recently reported from 
the Multicenter American Research Trial With Cilazapril 
After Angioplasty to Prevent Transluminal Obstruction and 
Restenosis (MARCATOR) trial (33) in which 90% angio- 
graphic follow-up was obtained. These investigators (33) found 
a restenosis rate of 50%, similar to the rates reported herein. 
Quantitative angiography was performed using electronic 
digital calipers as opposed to computerized quantitative an- 
giography with automatic edge detection. All measurements 
were performed by a single unblinded examiner, which could 
have introduced bias into the analysis. This was not likely to 
have a significant impact on the rate of restenosis, in which 
very conservative criteria were applied to maximize the rates of 
restenosis, but may have affected the analyses of outcome 
variables. 
Only 84% of follow-up angiograms were available for 
quantitative analysis. If the eight follow-up films not available 
for review were excluded and considered to be lacking angio- 
graphic follow-up, the calculated angiographic follow-up rate 
would be 75%, with a restenosis rate of 14%. Because this 
restenosis rate is lower than the 20% reported in the present 
study, these eight cases were included. The loss of data from 
these patients limits the ability to analyze angiographic fol- 
low-up variables, uch as follow-up minimal umen diameter or 
percent diameter stenosis. 
The small numbers in each subgroup may have precluded 
recognition of significant predictors of restenosis. With only 10 
cases of restenosis een in the present study, it would have 
been difficult to identify a prognostically important variable. 
The lack of association of final minimal umen diameter with 
restenosis, unlike that seen in many larger stent trials, may 
reflect the smaller numbers een in our study. Furthermore, 
the analysis of 22 variables with only 60 lesions is subject o 
type 1 errors, limiting the confidence that might be afforded 
any statistically significant findings. However, only the variable 
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of moderate to severe dissection was consistently seen as 
significant or nearly significant for each of the outcome 
variables and is therefore more likely to represent a realistic 
finding. Larger studies would be required to address these 
issues. 
Several potentially important variables could not be evalu- 
ated because the data were not available. The presence or 
absence of diabetes or tobacco use, for example, were not 
recorded for many of the earlier patients and could not be 
included in the analysis. 
Conclusions. Intracoronary stent deployment appears to 
be an effective adjunctive technique in reducing the rate of 
restenosis after opening of a chronic total coronary occlusion 
with balloon angioplasty. The angiographic restenosis rate of 
20% seen in this study compares favorably with historical 
restenosis rates of 50% to 60% when balloon angioplasty was 
used alone. Additionally, the majority of events were repre- 
sented by subtotal restenosis successfully treated with balloon 
angioplasty. In the present cohort, the presence of a moderate 
to severe dissection after opening of the occlusion, before stent 
implantation, was associated with a higher follow-up percent 
diameter stenosis and an increased rate of clinical events. The 
favorable results of the present observational study support the 
value of a randomized, controlled clinical trial comparing 
balloon angioplasty with stent-assisted balloon angioplasty for 
the treatment of chronic total coronary occlusions. 
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